HuagongsheHuagongshe Chemistry Print Report · For research reference only
3(2H)-Pyridazinone → HCID 13193370, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3(2H)-Pyridazinone | HCID 68153 | — |
| Reactant | HCID 13231139 | HCID 13231139 | — |
| Reactant | HCID 13771991 | HCID 13771991 | — |
| Reactant | HCID 21479294 | HCID 21479294 | — |
| Product | HCID 13193370 | HCID 13193370 | — |
Reaction Steps
A composition which comprises an effective blood pressure depressing, platelet aggregation inhibiting, or myocardial-contraction reinforcing amount of a compound selected from the group consisting of 6-[4-(N-carbobenzoxy-L-phenylalanylamino)-phenyl]-5-methyl -4,5-dihydro-3(2H)-pyridazinone, 6-[4-(L-phenylalanylamino)-phenyl-5-methyl-4,5-dihydro-3(2H)=pyridazinone, 6-]4-(N-carbobenzoxy-L-tryptophylamino)-phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, and 6-[4-(N-carbobenzoxy-L-asparaginylamino)-phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone; and a pharmaceutically acceptable carrier.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04965263 |
| Source dataset | uspto-grants-1990_10 |
| ORD ID | ord-dea87970a19a427e87a8d57723a0ad4e |
| Source note | uspto-grants-1990_10 |